A Phase 3, Multicenter, Open-Label, Two-Part Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of LeuprolideAcetate 45 mg 6-month formulation in Children with Central Precocious Puberty (CPP)

Project: Research project

Project Details

Description

A Phase 3, Multicenter, Open-Label, Two-Part Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Leuprolide Acetate 45 mg 6-month formulation in Children with Central Precocious Puberty (CPP)
StatusActive
Effective start/end date11/1/1811/1/22

Funding

  • ABBVIE INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.